Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis

Chest

Volumn 121, Issue 1, 2002, Pages 55-63

  Moss, Richard B ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aminoglycoside; Cystic fibrosis; Pseudomonas aeruginosa; Pulmonary function; Tobramycin

Indexed keywords

ANTIBIOTIC AGENT; CREATININE; TOBRAMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM COLONY; BODY MASS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; CREATININE URINE LEVEL; DISEASE COURSE; DRUG EFFECT; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; LONG TERM CARE; LUNG FIBROSIS; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; REMISSION; WEIGHT GAIN;

EID: 0036157901     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.121.1.55     Document Type: Article

References (18)

1. Cystic fibrosis: Molecular biology and therapeutic implications
2. Cystic fibrosis
3. Cystic fibrosis: Pathogenesis, pulmonary infection, and treatment
4. Prediction of mortality in patients with cystic fibrosis
5. Efficacy of aerosolized tobramycin in patients with cystic fibrosis
6. Effects of Pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis
7. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis
8. Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis
9. Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection
10. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis
11. Changes in the normal maximal expiratory flow-volume curve with growth and aging
12. Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis
13. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto
14. Nutrition in adults with cystic fibrosis
15. Determinants of mortality from cystic fibrosis in Canada, 1970-1989
16. Nutritional state and lung disease in cystic fibrosis